Zydus Lifesciences reports stellar Q1FY25 performance with highest ever operating profit and margin, driven by the US and India. The company reiterates high teens revenue growth guidance for FY25.
What is covered in the Full Insight:
Q1FY25 Result Highlights And FY25 Guidance
Record High US Revenue
Accelerated Double-digit Revenue Growth In India
US Business to Accelerate Further
Recommendation
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.